EU approves Moderna’s Covid vaccine for kids aged 12-17

The European Medicines Agency (EMA) on Friday accepted the usage of Moderna’s Covid-19 vaccine for kids aged 12 to 17. The Moderna vaccine shall be administered in two doses, 4 weeks aside (Photo: File)The European medicines watchdog on Friday accepted the usage of Moderna’s coronavirus vaccine for kids aged 12 to 17, making it the second jab for adolescents to be used on the continent.

“The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above,” the European Medicines Agency (EMA) mentioned, utilizing Moderna’s model title.The vaccine shall be given in two injections, every 4 weeks aside.The determination by the Amsterdam-based company follows the approval of the primary vaccine for European kids, by Pfizer/BioNTech in May.The results of Spikevax have been studied amongst 3,732 youngsters aged 12 to 17 years, the EMA mentioned.”The study showed that Spikevax produced a comparable antibody response in 12 to 17-year-olds to that seen in young adults aged 18 to 25 years,” it mentioned.Read | India to get 7.5 million doses of Moderna vaccine via COVAX programme: WHOClick right here for IndiaAs we speak.in’s full protection of the coronavirus pandemic.